The R21 malaria vaccine is about to get cheaper, thanks to a new deal between UNICEF and the Serum Institute of India, the world’s largest vaccine manufacturer, with financial backing from Gavi, the Vaccine Alliance.
Under the agreement, the vaccine’s price will come down to $2.99 from $3.90 per dose.
According to Gavi, the deal was made possible by utilizing funding from the International Finance Facility for Immunisation, or IFFIm, an innovative financial instrument that raises funding for Gavi’s child immunization work through the issuance of vaccine bonds on capital markets.